These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 8583558)
21. [A double-blind trial on the effect of alpha-adrenergic blocker (bunazosin hydrochloride) in the symptomatic treatment of prostatism]. Kumamoto Y; Yokoyama E; Tsukamoto T; Tsuchida S; Nishizawa O; Koshiba K; Ishibashi A; Ogawa A; Tomita Y; Aso Y Hinyokika Kiyo; 1987 Oct; 33(10):1681-702. PubMed ID: 2451409 [TBL] [Abstract][Full Text] [Related]
22. [Efficiency and tolerance of terazosine in ambulatory patients with benign prostatic hypertrophy: comparative randomized and double-blind trial versus alfuzosin. The MG Terazosine Group]. Fourcade RO Prog Urol; 2000 Apr; 10(2):246-53. PubMed ID: 10857142 [TBL] [Abstract][Full Text] [Related]
23. Initial, long-term, and durable responses to terazosin, placebo, or other therapies for chronic prostatitis/chronic pelvic pain syndrome. Cheah PY; Liong ML; Yuen KH; Teh CL; Khor T; Yang JR; Yap HW; Krieger JN Urology; 2004 Nov; 64(5):881-6. PubMed ID: 15533470 [TBL] [Abstract][Full Text] [Related]
24. Efficacy of selective alpha-1 blocker therapy in the treatment of acute urinary symptoms during radiotherapy for localized prostate cancer. Zelefsky MJ; Ginor RX; Fuks Z; Leibel SA Int J Radiat Oncol Biol Phys; 1999 Oct; 45(3):567-70. PubMed ID: 10524407 [TBL] [Abstract][Full Text] [Related]
25. Terazosin for BPH. Jerant AF J Fam Pract; 1995 Mar; 40(3):222-3. PubMed ID: 7533204 [No Abstract] [Full Text] [Related]
26. [Patterns of use of terazosine in current medical practice in ambulatory patients with obstructive and irritative obstructive disorders of urination]. Serment G; Rossi D; Reitz C; Boumendil O Prog Urol; 2000 Apr; 10(2):254-60. PubMed ID: 10857143 [TBL] [Abstract][Full Text] [Related]
27. Terazosin in mild hypertension: experience in open trials. Rosenthal J Br J Clin Pract Suppl; 1987 Dec; 54():32-44. PubMed ID: 2905160 [No Abstract] [Full Text] [Related]
28. [Efficacy of setegis administration after transvesical adenomectomy]. Gorilovskiĭ LM; Zingerenko MB; Lakhno DA Urologiia; 2007; (6):61, 63-5. PubMed ID: 18649663 [TBL] [Abstract][Full Text] [Related]
29. Clinical experience: symptomatic management of BPH with terazosin. Dunzendorfer U Urology; 1988 Dec; 32(6 Suppl):27-31. PubMed ID: 2462302 [TBL] [Abstract][Full Text] [Related]
31. Effects of terazosin in the treatment of benign prostatic hyperplasia. A pilot study. Dunzendorfer U Arzneimittelforschung; 1989 Oct; 39(10):1289-91. PubMed ID: 2482025 [TBL] [Abstract][Full Text] [Related]
32. Prevention of postherniorrhaphy urinary retention with prazosin. Gönüllü NN; Dülger M; Utkan NZ; Cantürk NZ; Alponat A Am Surg; 1999 Jan; 65(1):55-8. PubMed ID: 9915533 [TBL] [Abstract][Full Text] [Related]
33. Treatment of idiopathic oligozoospermia with an alpha-blocker: a placebo-controlled double-blind trial. Gregoriou O; Vitoratos N; Papadias C; Gargaropoulos A; Konidaris S; Giannopoulos V; Chryssicopoulos A Int J Fertil Womens Med; 1997; 42(5):301-5. PubMed ID: 9406835 [TBL] [Abstract][Full Text] [Related]
34. Effect of terazosin on prostatism in men with normal and abnormal peak urinary flow rates. Lepor H; Nieder A; Feser J; O'Connell C; Dixon C Urology; 1997 Mar; 49(3):476-80. PubMed ID: 9123722 [TBL] [Abstract][Full Text] [Related]
35. Efficacy and safety of combined therapy with terazosin and tolteradine for patients with lower urinary tract symptoms associated with benign prostatic hyperplasia: a prospective study. Yang Y; Zhao XF; Li HZ; Wang W; Zhang Y; Xiao H; Zhang X Chin Med J (Engl); 2007 Mar; 120(5):370-4. PubMed ID: 17376305 [TBL] [Abstract][Full Text] [Related]